Core Laboratories Inc.
American service Provider
CLB NYSE
ISIN NL0000200384 SEC CIK 1958086 LEI 724500MDYY5VBSAF5W50
Follow Core Laboratories
Weekly email: filings, results
Revenue, last quarter
$132.1M
−1.8% vs same quarter last year
Net income
$5.4M
−61.8% vs same quarter last year
EPS, diluted
$0.12
−60% vs same quarter last year
Operating cash flow
$5M
−41.6% vs same quarter last year
Source: SEC XBRL filings · latest filing